• In the treatment of various coronary artery diseases (CAD) for select indications

• Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective

International cardiologists are endorsing the use of special drug-coated balloons as a fit and necessary alternative to drug eluting stents in the treatment of various coronary artery diseases (CAD) for select indications. This alternative is especially valuable for young patients with multiple blocks and underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective.

“The utilization of drug-coated balloons in coronary intervention is consistently growing” stated Prof Antonio Colombo, Director, Humanitas Research Hospital, Milan. “Initially developed to address in-stent restenosis and avoid additional stenting, their application has now expanded to de novo lesions, particularly in cases of small vessel diffuse disease, where the risk of restenosis and stent thrombosis is high. Diabetic patients, highly prevalent in India, often present with diffuse diseases. Moreover, there has been an increase in the incidence of coronary artery disease normally known as Heart attacks, particularly among young patients. For these subsets of patients and lesions, stenting is not an ideal solution, and drug-coated balloons offer an excellent alternative to metal scaffolding. The MagicTouch Sirolimus Coated Balloon (SCB), with its notable and proven safety profile and efficacy, has been in use since 2015.”

Dr. Sandeep Basavarajaiah, Consultant Cardiologist, Birmingham Heartlands Hospital, UK added, “The MagicTouch device demonstrates excellent deliverability, even in complex tortuous coronary arteries. In cases of diffuse disease requiring longer balloons, it is crucial to deliver them within two minutes of introducing them into the guiding catheter to minimize drug loss during transit. With its exceptional deliverability, the MagicTouch is an ideal choice for long-diffuse lesions, including in-stent restenosis.”

Prof Antonio Colombo and Dr Sandeep Basavarajaiah shared their expertise at the educational session cum knowledge feast titled “Sirolimus Drug Coated Balloons (DCB): Expanding the Scope of Coronary Artery Diseases (CAD)” organized by Concept Medical. The knowledge feast was attended by over 100 esteemed cardiologists, who also benefited from the knowledge and experiences shared by other senior cardiologists, including renowned cardiologist from Mumbai namely Dr Kirti Punamiya, Dr Ajit Menon, Dr V. T. Shah, Dr Anand Rao, Dr Nimit Shah, and Dr Rahul Gupta. The esteemed international faculty joined the panel of the above doctors and displayed the upcoming technology and alternative of Drug-Coated Balloon in action with multiple case presentations and talks.

Dr. Manish Doshi, MD, Concept Medical & Inventor of the World’s First Sirolimus Drug Coated Balloon explained the revolutionary technology behind this treatment option, “The drug and carrier complex of the balloon is specifically designed to penetrate the inner layers of vessel walls and act as a reservoir for the long-term release of medicine. This mechanism effectively prevents re-narrowing of the coronary artery.”